Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |